Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid)

2007 ◽  
Vol 45 (4) ◽  
pp. 424-428 ◽  
Author(s):  
Aud-E. Stenehjem ◽  
Marie Vahter ◽  
Barbro Nermell ◽  
Jorulf Aasen ◽  
Syverin Lierhagen ◽  
...  
1981 ◽  
Vol 47 (3) ◽  
pp. 241-243 ◽  
Author(s):  
K. Lenz ◽  
K. Hruby ◽  
W. Druml ◽  
A. Eder ◽  
A. Gaszner ◽  
...  

2003 ◽  
Vol 41 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Philippe Hantson ◽  
Vincent Haufroid ◽  
Jean-Pierre Buchet ◽  
Paul Mahieu

Author(s):  
Pham Thi Thanh Tam ◽  
Phan Viet Hai ◽  
Nguyen Thi Nga ◽  
Duong Dinh Cua ◽  
Nguyen Thi Mai

Arsenic is a poisoning metallic element, in which trivalent inorganic arsenic compounds are considered unique. Children can be exposed from arsenic containing water, food and folk remedies with unclear ingredients [1]. The main toxic mechanism of As3+ is inhibition of the pyruvate dehydrogenase (PDH) complex, which leads to decrease in acetyl-CoA production, decrease in cellular respiration and free oxygen radical (0-) and hydrogen peroxide (H202) are born, which make cytotoxic. Arsenic poisoning causes damage to multiple organs: keratosis of the skin, nail and squamous cell cancer, neuropathy, repolarization of the myocardium, liver damage and subsequent sequelaes [1], [2]. Arsenic poisoning has no specific symptoms, so it is easy to overlook, especially in children [2]. The epidemiological exploitation and history of poisoning drugs are very important to avoid missing arsenic poisoning. We report a case of successfully treated arsenic poisoning at the Vietnam National Children’s Hospital.


1995 ◽  
Vol 26 (2) ◽  
pp. 239-245
Author(s):  
HELMUT KREPPEL ◽  
FRANZ X. REICHL ◽  
ANDREAS KLEINE ◽  
LADISLAUS SZINICZ ◽  
PRAMOD K. SINGH ◽  
...  

2013 ◽  
Vol 28 (2) ◽  
pp. 128-131
Author(s):  
Sharif Uddin Ahmed ◽  
Md Masud Rana ◽  
Md Rafiqul Islam ◽  
Hasan Zahidur Rahman ◽  
Moniruzzaman Bhuiyan ◽  
...  

Chronic Arsenic Toxicity may have varied clinical presentations ranging from non-cancerous manifestations to malignancy of skin and different internal organs. Chronic arsenic exposure results in dermatologic manifestations prior to overt clinical neuropathy. Arsenic neuropathy causes painful paresthesias and, with higher level or continued exposure, length-dependent weakness. We are reporting two cases of chronic arsenic poisoning who presented initially as peripheral sensory motor neuropathy and skin manifestations. Arsenic poisoning was suspected because many of the other family members also developed similar symptoms simultaneously. The hair samples of these patients contained markedly elevated levels of arsenic. Also the water samples from their household and the neighboring households were found to have alarming levels of inorganic arsenic. Provision of arsenic free drinking water halt further deterioration of symptoms and there was significant improvement of their dermatological & neurological conditions. DOI: http://dx.doi.org/10.3329/bjn.v28i2.17184 Bangladesh Journal of Neuroscience 2012; Vol. 28 (2): 128-131


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Victoria K. Mwaeni ◽  
James N. Nyariki ◽  
Ngalla Jillani ◽  
George Omwenga ◽  
Mathew Ngugi ◽  
...  

Abstract Background Arsenic poisoning affects millions of people. The inorganic forms of arsenic are more toxic. Treatment for arsenic poisoning relies on chelation of extracellularly circulating arsenic molecules by 2,3-dimecaptosuccinic acid (DMSA). As a pharmacological intervention, DMSA is unable to chelate arsenic molecules from intracellular spaces. The consequence is continued toxicity and cell damage in the presence of DMSA. A two-pronged approach that removes extracellular arsenic, while protecting from the intracellular arsenic would provide a better pharmacotherapeutic outcome. In this study, Coenzyme Q10 (CoQ10), which has been shown to protect from intracellular organic arsenic, was administered separately or with DMSA; following oral exposure to sodium meta-arsenite (NaAsO2) – a very toxic trivalent form of inorganic arsenic. The aim was to determine if CoQ10 alone or when co-administered with DMSA would nullify arsenite-induced toxicity in mice. Methods Group one represented the control; the second group was treated with NaAsO2 (15 mg/kg) daily for 30 days, the third, fourth and fifth groups of mice were given NaAsO2 and treated with 200 mg/kg CoQ10 (30 days) and 50 mg/kg DMSA (5 days) either alone or in combination. Results Administration of CoQ10 and DMSA resulted in protection from arsenic-induced suppression of RBCs, haematocrit and hemoglobin levels. CoQ10 and DMSA protected from arsenic-induced alteration of WBCs, basophils, neutrophils, monocytes, eosinophils and platelets. Arsenite-induced dyslipidemia was nullified by administration of CoQ10 alone or in combination with DMSA. Arsenite induced a drastic depletion of the liver and brain GSH; that was significantly blocked by CoQ10 and DMSA alone or in combination. Exposure to arsenite resulted in significant elevation of liver and kidney damage markers. The histological analysis of respective organs confirmed arsenic-induced organ damage, which was ameliorated by CoQ10 alone or when co-administered with DMSA. When administered alone, DMSA did not prevent arsenic-driven tissue damage. Conclusions Findings from this study demonstrate that CoQ10 and DMSA separately or in a combination, significantly protect against arsenic-driven toxicity in mice. It is evident that with further pre-clinical and clinical studies, an adjunct therapy that incorporates CoQ10 alongside DMSA may find applications in nullifying arsenic-driven toxicity.


Planta Medica ◽  
2012 ◽  
Vol 78 (11) ◽  
Author(s):  
C Ubonnuch ◽  
S Ruangwises ◽  
N Ruangwises ◽  
W Gritsanapan
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document